P2.205 A phase I/II clinical trial to evaluate the safety and efflcacy of ProSavin®, a gene therapy approach for Parkinson's disease

Saved in:
Bibliographic Details
Title: P2.205 A phase I/II clinical trial to evaluate the safety and efflcacy of ProSavin®, a gene therapy approach for Parkinson's disease
Authors: Jarraya, B., Lepetit, H., Ralph, S., Boulet, S., Jan, C., Bonvento, G., Miskin, J., Gurruchaga, J.-M., Vinti, M., Fenelon, G., Brugière, P., Kingsman, S., Hantraye, P., Remy, P., Mitrophanous, K., Palfl, S.
Source: Parkinsonism & Related Disorders. Dec2009 Supplement 2, Vol. 15, pS145-S145. 1p.
Database: Academic Search Ultimate
Description
ISSN:13538020
DOI:10.1016/S1353-8020(09)70556-5